Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oligopin Supplementation in Postmenopausal Osteopenic Women
NCT03260803Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of french maritime pine bark extract in osteopenia, sponsored by Tehran University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
french maritime pine bark extract
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT03260803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260803.